It seems pretty obvious what Uni-Pharma's intentions are regarding Onko-Sure:
"The product is unique. Onko-Sure uses a biomarker that is significantly underutilized. If we can bring it to the market with the right strategy, we will gain market share very quickly. A number of countries have already expressed strong interest in offering Onko-Sure within the parameters of their health insurance systems."
News 
Market Data 
Discover 
